18.9.2026 15:45:00 CEST |Globenewswire |Press release
Share
Lassila & Tikanoja Plc’s financial information and AGM in 2027
Lassila & Tikanoja Plc
Stock exchange release
18 September 2026 at 4:45 PM EEST
In the year 2027 Lassila & Tikanoja Plc will disclose financial information as follows:
Financial Statements Release 2026: Friday 12 February 2027 at 8.00 am
Interim Report January–March: Tuesday 27 April 2027 at 8.00 am
Half-year Financial Report January–June: Thursday 5 August 2027 at 8.00 am
Interim Report January–September: Wednesday 27 October 2027 at 8.00 am
Lassila & Tikanoja Plc’s Annual Report 2026 will be published on the Group’s website at <a href="https://www.globenewswire.com/Tracker?data=att_7SBNsm2WFS-P74tJdTxkzi7OoKsofGjUObAq2mvRQVGStNeHnPssa1j3l77xJZCKvRFx2eZxxdXeTJJVxyH2Oal_fLKj5gTDJvNCqxTcsyXsSuY-lSuZ6VNL9vX3A9ygGJ3coFXFU7-hYlfZ_0-Hh9qRSe2SPag3H6r1sQ9ib2RlzbdVyo32qmUquqOqZGLAk1waFU2AJ4IcOoCm72Tkvqz6pIvIsCMuMWqb7V0=” rel=”nofollow noopener” target=”_blank”>www.lt.fi/en during week 9.
The Annual General Meeting is tentatively scheduled for Wednesday 24 March 2027. The Board of Directors will decide on the summoning of the meeting at a later date.
Additional information:
Joni Sorsanen, CFO, tel. +358 50 443 3045
Lassila & Tikanoja is a leading Nordic circular economy company committed to unleashing the potential of circularity together with its customers and partners. Our services include waste management and recycling, hazardous waste and remediation services as well as industrial services and water treatment. Our goal is to strengthen an efficient infrastructure in society and promote the sustainable use of materials by transforming waste streams into valuable raw materials. L&T employs approximately 2,300 people in Finland and Sweden and is listed on Nasdaq Helsinki.
Distribution:
Nasdaq Helsinki
Major media
www.lt.fi/en
Latest releases from Globenewswire
CGTN19.9.2026 08:41:28 CEST | Press release
CGTN：CGTN Poll | Why is the SCO Solution for Global Governance Drawing Wide Attention?
Teva Pharmaceutical Industries Ltd18.9.2026 22:32:00 CEST | Press release
New Teva Study Identifies the Attributes that Healthcare Providers Prioritize when Selecting a Treatment for Tardive Dyskinesia in Older Patients
Teva Pharmaceutical Industries Ltd18.9.2026 22:31:00 CEST | Press release
Teva Highlights New Real-World Data Showing UZEDY® (risperidone) Outperforms Other Long-Acting Injectables in Keeping Schizophrenia Patients on Treatment, While Reducing Emergency Care and Healthcare Costs
Teva Pharmaceutical Industries Ltd18.9.2026 22:30:00 CEST | Press release
Teva Announces New Olanzapine LAI (TEV-‘749) Post Hoc Data Highlighting High Rates of Stabilization and Long-Term Efficacy as Once-Monthly Subcutaneous Injectable for the Treatment of Schizophrenia in Adults
Leading Edge Materials Corp.18.9.2026 20:30:00 CEST | Press release
LEADING EDGE MATERIALS REPORTS QUARTERLY RESULTS TO JULY 31, 2026 AND ANNOUNCES CLOSING OF THE SECOND TRANCHE OF PRIVATE PLACEMENT
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
